Skip to main content
padlock icon - secure page this page is secure

Cost analysis of the treatment of acute childhood lymphocytic leukaemia according to Nordic protocols

Buy Article:

$52.00 + tax (Refund Policy)

Some attempts have been made to reduce the costs incurred in the therapy of leukaemia, but no studies are available regarding costs of the entire treatment in children with acute lymphocytic leukaemia (ALL). We analysed all the direct costs of treatment of 11 children with ALL diagnosed and treated in Kuopio University Hospital. The follow‐up continued from diagnosis until the end of treatment for each patient. Patient treatment on the ward lasted for 84‐210 d and in the outpatient clinic for 24‐66 d, depending on the risk group. From 11‐54 of the inpatient days were required for the treatment of infections. Total mean cost of the entire treatment was US $103 250 (US $55 196‐166 039) per patient, 53% of which were basic hospital costs and 47% patient‐specific costs. Laboratory tests and radiology accounted for 18% of all direct costs and cytostatic drugs for 13%, but blood products accounted for only 4% of the total. Infections were the most important extra cause of costs, accounting for 18% of the mean total costs per patient.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Acute lymphocytic leukaemia; children; costs; treatment

Document Type: Research Article

Affiliations: Department of Pediatrics, Kuopio University Hospital, University of Kuopio, Kuopio, Finland

Publication date: April 1, 2000

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more